NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Funding Amount
Up to $4,500,000
Deadline
Forecast — dates not yet posted
Number of Awards
30
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Open to all applicant types
Overview
This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance monitoring in retail food specimens within the NARMS program. The NARMS cooperative agreements is intended to improve the detection of antibiotic resistance among bacteria in food commodities, as well as expand to new sites to expand the scope of sampling. Measurable outcomes of the program will be in alignment with the NARMS Objectives.
Details
- Agency: Food and Drug Administration
- Department: Department of Health and Human Services
- Opportunity #: FOR-FD-25-014
- Expected Awards: 30
- Instrument: cooperative_agreement
Focus Areas & Funding Uses
Fields of Work
- Science research
- Food security
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration
Amount
Up to $250,000
Deadline
January 29, 2027
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
Food and Drug Administration
Amount
Up to $300,000
Deadline
April 1, 2027
Laboratory Flexible Funding Model (LFFM)
Food and Drug Administration
Amount
Up to $1,500,000
Deadline
January 11, 2028
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration
Amount
Up to $600,000
Deadline
February 8, 2028
Animal and Veterinary Innovation Centers (U18)
Food and Drug Administration
Amount
Up to $1,250,000
Deadline
May 12, 2028
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration
Amount
Up to $900,000
Deadline
May 16, 2028
Ready to apply for NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens. Now let's win it.